Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care
Roongroj Bhidayasiri, Sasivimol Virameteekul, Jong‐Min Kim, et al.
Journal of Movement Disorders (2020) Vol. 13, Iss. 2, pp. 105-114
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Impact of COVID-19 in the Mental Health in Elderly: Psychological and Biological Updates
Roberta Eduarda Grolli, Maiqueli Eduarda Dama Mingoti, Amanda Gollo Bertollo, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 5, pp. 1905-1916
Open Access | Times Cited: 229
COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
David Sulzer, Angelo Antonini, Valentina Leta, et al.
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 165
The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease
Ethan Brown, Lana M. Chahine, Samuel M. Goldman, et al.
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 4, pp. 1365-1377
Open Access | Times Cited: 159
How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review
A. Langer, Lucia Gassner, Anna Flotz, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 67
Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross‐Sectional Survey of 568 Spanish Patients
Diego Santos‐García, M. B. Oreiro, Patricia Pérez, et al.
Movement Disorders (2020) Vol. 35, Iss. 10, pp. 1712-1716
Open Access | Times Cited: 63
Risk of Hospitalization and Death for COVID ‐19 in People with Parkinson's Disease or Parkinsonism
Luca Vignatelli, Corrado Zenesini, Laura Maria Beatrice Belotti, et al.
Movement Disorders (2020) Vol. 36, Iss. 1, pp. 1-10
Open Access | Times Cited: 54
Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19
Dipak Kumar, Sadaf Jahan, Andleeb Khan, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 7, pp. 3417-3434
Open Access | Times Cited: 49
Neurological toll of COVID-19
Shivam Bhola, Jhillika Trisal, Vikram Thakur, et al.
Neurological Sciences (2022) Vol. 43, Iss. 4, pp. 2171-2186
Open Access | Times Cited: 38
Neurological consultations and diagnoses in a large, dedicated COVID-19 university hospital
Adalberto Studart‐Neto, Bruno Fukelmann Guedes, Raphael de Luca e Tuma, et al.
Arquivos de Neuro-Psiquiatria (2020) Vol. 78, Iss. 8, pp. 494-500
Open Access | Times Cited: 48
The Impact of COVID‐19 on Access to Parkinson's Disease Medication
Julia L.Y. Cheong, Zhao Hang Keith Goh, Connie Marras, et al.
Movement Disorders (2020) Vol. 35, Iss. 12, pp. 2129-2133
Open Access | Times Cited: 46
Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain & COVID-19 pan-Canadian study
Lise Dassieu, M. Gabrielle Pagé, Anaïs Lacasse, et al.
International Journal for Equity in Health (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 40
Clinical Profiles and Mortality of COVID‐19 Inpatients with Parkinson's Disease in Germany
Raphael Scherbaum, Eun Hae Kwon, Daniel Richter, et al.
Movement Disorders (2021) Vol. 36, Iss. 5, pp. 1049-1057
Open Access | Times Cited: 39
Covid-19 and Parkinson’s disease: an overview
Sandy Maria Cartella, Carmen Terranova, Vincent Rizzo, et al.
Journal of Neurology (2021) Vol. 268, Iss. 12, pp. 4415-4421
Open Access | Times Cited: 34
Efficacy of non-immersive virtual reality-based telerehabilitation on postural stability in Parkinson's disease: a multicenter randomized controlled trial
Michela Goffredo, Francesca Baglio, Roberto De Icco, et al.
European Journal of Physical and Rehabilitation Medicine (2023) Vol. 59, Iss. 6
Open Access | Times Cited: 15
Dyspnea: An underestimated symptom in Parkinson's disease
Guillaume Baille, Cécile Chenivesse, T. Pérez, et al.
Parkinsonism & Related Disorders (2018) Vol. 60, pp. 162-166
Open Access | Times Cited: 46
Motor and non-motor function predictors of mortality in Parkinson’s disease
Paulo Bugalho, Filipa Ladeira, Raquel Barbosa, et al.
Journal of Neural Transmission (2019) Vol. 126, Iss. 11, pp. 1409-1415
Closed Access | Times Cited: 32
COVID-19 social distancing: negative effects on people with Parkinson disease and their associations with confidence for self-management
Galit Yogev‐Seligmann, Michal Kafri
BMC Neurology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Update on Neurological Manifestations of SARS-CoV-2
Hisham Valiuddin, Almir Kalajdzic, James Rosati, et al.
Western Journal of Emergency Medicine (2020) Vol. 21, Iss. 6
Open Access | Times Cited: 27
Potential impact and challenges associated with Parkinson’s disease patient care amidst the COVID-19 global pandemic
Ali Elbeddini, Anthony To, Yasamin Tayefehchamani, et al.
Journal of Clinical Movement Disorders (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 26
Parkinson’s Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy
Smriti Sinha, Swati Mittal, Rupali Roy
Journal of Movement Disorders (2021) Vol. 14, Iss. 3, pp. 184-192
Open Access | Times Cited: 21
COVID-19 and Parkinson’s disease: a systematic review and meta-analysis
Maryam Afraie, Ghobad Moradi, Pardis Mohammadzedeh, et al.
Acta Neurologica Belgica (2022) Vol. 123, Iss. 4, pp. 1209-1223
Open Access | Times Cited: 16
The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design
Konrad Rejdak, Piotr Fiedor, Robert Bonek, et al.
Contemporary Clinical Trials (2022) Vol. 116, pp. 106755-106755
Open Access | Times Cited: 15
Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) among Patients at a Movement Disorders Center
Joy Antonelle de Marcaida, Jeffrey Lahrmann, Duarte Machado, et al.
Geriatrics (2020) Vol. 5, Iss. 3, pp. 54-54
Open Access | Times Cited: 22
Dance as Lifeline: Transforming Means for Engagement and Connection in Times of Social Isolation
Maria Portman Kelly, David Leventhal
Health Promotion Practice (2021) Vol. 22, Iss. 1_suppl, pp. 64S-69S
Open Access | Times Cited: 20
Impact of Prolonged Lockdown due to COVID-19 in Patients with Parkinson's Disease
PramodKumar Pal, Shweta Prasad, Vikram V. Holla, et al.
Neurology India (2020) Vol. 68, Iss. 4, pp. 792-792
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top